Skip to main content
Addgene

High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells.

Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, Sander JD
Nat Biotechnol. 2013 Jun 23. doi: 10.1038/nbt.2623. (Link opens in a new window) PubMed (Link opens in a new window) Article


CRISPR-Cas/RGN expression plasmids for EGFP and Human genes

The paper describes the use of CRISPR-Cas/RNA-Guided Nuclease (RGN) technology to modify three different sites in the EGFP reporter gene (Addgene plasmid #47511–47513) and four different endogenous human genes (Addgene plasmid #47505–47510).

Note that gRNA produced from each of these vectors were used in conjunction with mRNA produced from the mammalian codon-optimized Cas9 expression vector (JDS246). Additional details can be found in the paper and users are encouraged to post questions to the Genome Engineering newsgroup (which can be joined here (Link opens in a new window)).

Plasmids from Article

ID Plasmid Purpose
47505pVC297 VEGF Site#1human gRNA expression vector targeting VEGF
47506pVC299 VEGF Site#2human gRNA expression vector targeting VEGF
47507pVC228 VEGF Site#3human gRNA expression vector targeting VEGF
47508pFYF1548 EMX1human gRNA expression vector targeting EMX1
47509pDR366 RNF2human gRNA expression vector targeting RNF2
47510pDR348 FANCFhuman gRNA expression vector targeting FANCF
47511pFYF1320 EGFP Site#1human gRNA expression vector targeting EGFP
47512pFYF1327 EGFP Site#2human gRNA expression vector targeting EGFP
47513pFYF1328 EGFP Site#3human gRNA expression vector targeting EGFP

Antibodies from Article